BlackRock Amends Abbott Labs Stake, Signals Continued Confidence

Ticker: ABT · Form: SC 13G/A · Filed: 2024-01-26T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**BlackRock still holds Abbott Labs, showing big institutional confidence.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of Abbott Laboratories' Common Stock as of December 31, 2023. This is Amendment No. 12 to their previous filings, showing BlackRock continues to be a significant institutional holder of Abbott Laboratories shares. This matters to investors because BlackRock is one of the world's largest asset managers, and their continued substantial holding signals confidence in Abbott Laboratories' long-term prospects, potentially influencing other institutional and retail investors.

Why It Matters

BlackRock's ongoing significant ownership in Abbott Laboratories suggests institutional confidence, which can positively influence market perception and stability for current and prospective shareholders.

Risk Assessment

Risk Level: low — This filing is routine for large institutional investors and does not indicate any immediate negative or positive risk for the stock.

Analyst Insight

Investors should note BlackRock's continued presence as a major shareholder, which can be a positive signal of institutional confidence, but this filing alone doesn't warrant immediate buying or selling action.

Key Players & Entities

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, specifically Amendment No. 12.

Who is the reporting person in this filing?

The reporting person is BlackRock, Inc., identified by CIK 0001364742.

What company's securities are being reported on?

The securities being reported on are the Common Stock of Abbott Laboratories, identified by CIK 0000001800.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.

Under which rule is this Schedule 13G filed?

This Schedule 13G is filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.

From the Filing

0001086364-24-004264.txt : 20240126 0001086364-24-004264.hdr.sgml : 20240126 20240126114938 ACCESSION NUMBER: 0001086364-24-004264 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-10519 FILM NUMBER: 24565741 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us0028241000_012624.txt us0028241000_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) ABBOTT LABORATORIES -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 002824100 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 002824100 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 120538358 (6) Shared voting power 0 (7) Sole dispositive power 134061311 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 134061311 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 7.7% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- ABBOTT LABORATORIES Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: -------------

View on Read The Filing